Clinical Trial Update: Safety and Efficacy of Targeted Gene Transfer in Colorectal Cancer Metastatic to Liver [Phase 1, Phase 2]

View source ↗

Summary

The clinical trial evaluating targeted gene transfer for colorectal cancer with liver metastases (Phase 1/2) has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Snippet

Sponsor: University of Southern California | Conditions: Colorectal Neoplasms | Phase 1, Phase 2 | Status: WITHDRAWN